CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY / MEMBERS' CAPITAL - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Notes Receivable	Notes Receivable Cumulative Effect, Period of Adoption, Adjusted Balance	Class A Shares	Class B Shares	Members' Capital	Members' Capital Cumulative Effect, Period of Adoption, Adjustment	Members' Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock Class A Shares	Common Stock Class A Shares Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock Class B Shares	Common Stock Class B Shares Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjusted Balance	Non-Controlling Interests	Non-Controlling Interests Cumulative Effect, Period of Adoption, Adjusted Balance
Balance at the beginning (in shares) at Dec. 31, 2020								14,629,533	292,214,129	306,843,662
Balance at the beginning at Dec. 31, 2020	$ 49,625	$ 0	$ 49,625	$ (134)	$ (134)			$ 157,591	$ (157,560)	$ 31		$ 0		$ 0	$ 0	$ 157,560	$ 157,560	$ (107,832)	$ (107,832)		$ 0
Balance at the beginning (in shares) at Dec. 31, 2020												0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss prior to business combination	(65,213)																	(65,213)
Business combination and PIPE financing (in shares)								(306,843,662)			166,243,491		306,843,662
Business combination and PIPE financing	773,093							$ (31)			$ 17		$ 31		169,093			112,306		$ 491,677
Stock-based compensation expense	3,680														3,680
Issuance of common stock for acquisitions (in shares)											4,055,698
Issuance of common stock for acquisitions	60,000														60,000
Impact of transactions affecting non-controlling interests	0														(34,094)					34,094
Notes receivable - related parties	(2)			(2)
Net income (loss)	12,810																	4,552		8,258
Balance at the end (in shares) at Jun. 30, 2021								0
Balance at the end at Jun. 30, 2021	833,993			(136)				$ 0			$ 17		$ 31		356,239			(56,187)		534,029
Balance at the end (in shares) at Jun. 30, 2021											170,299,189		306,843,662
Balance at the beginning (in shares) at Mar. 31, 2021								14,629,533	292,214,129	306,843,662
Balance at the beginning at Mar. 31, 2021	33,584	$ 0	$ 33,584	(135)	$ (135)			$ 157,662	$ (157,631)	$ 31		$ 0		$ 0	0	$ 157,631	$ 157,631	(123,943)	$ (123,943)		$ 0
Balance at the beginning (in shares) at Mar. 31, 2021												0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss prior to business combination	(49,102)																	(49,102)
Business combination and PIPE financing (in shares)								(306,843,662)			166,243,491		306,843,662
Business combination and PIPE financing	773,093							$ (31)			$ 17		$ 31		169,093			112,306		491,677
Stock-based compensation expense	3,609														3,609
Issuance of common stock for acquisitions (in shares)											4,055,698
Issuance of common stock for acquisitions	60,000														60,000
Impact of transactions affecting non-controlling interests	0														(34,094)					34,094
Notes receivable - related parties	(1)			(1)
Net income (loss)	12,810																	4,552		8,258
Balance at the end (in shares) at Jun. 30, 2021								0
Balance at the end at Jun. 30, 2021	833,993			$ (136)				$ 0			$ 17		$ 31		356,239			(56,187)		534,029
Balance at the end (in shares) at Jun. 30, 2021											170,299,189		306,843,662
Balance at the beginning at Dec. 31, 2021	798,568										$ 18		$ 30		397,443			(78,760)		479,837
Balance at the beginning (in shares) at Dec. 31, 2021						180,113,551	297,385,981				180,113,551		297,385,981
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	31,600														31,600
Issuance of Class A common stock upon vesting of restricted stock units (in shares)											807,315
Issuance of Class A common stock upon vesting of restricted stock units	0										$ 1				(5,086)					5,085
Issuance of common stock for acquisitions (in shares)											2,857,167
Issuance of common stock for acquisitions	15,771														15,771
Exchange of Class B common stock for Class A common stock (in shares)											32,858,547		(32,858,547)
Exchange of Class B common stock for Class A common stock	0										$ 3		$ (3)		51,765					(51,765)
ESPP Issuance (in shares)											1,392,372
Exchange of Class B common stock for Class A common stock	9,707														9,707
Impact of transactions affecting non-controlling interests	0														(5,558)					5,558
Net income (loss)	(14,649)																	(4,673)		(9,976)
Balance at the end at Jun. 30, 2022	840,997										$ 22		$ 27		495,642			(83,433)		428,739
Balance at the end (in shares) at Jun. 30, 2022						218,028,952	264,527,434				218,028,952		264,527,434
Balance at the beginning at Mar. 31, 2022	837,777										$ 20		$ 28		464,262			(78,100)		451,567
Balance at the beginning (in shares) at Mar. 31, 2022											205,026,367		276,722,704
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	17,783														17,783
Issuance of Class A common stock upon vesting of restricted stock units (in shares)											807,315
Issuance of Class A common stock upon vesting of restricted stock units	0										$ 1				(5,086)					5,085
Exchange of Class B common stock for Class A common stock (in shares)											12,195,270		(12,195,270)
Exchange of Class B common stock for Class A common stock	0										$ 1		$ (1)		18,682					(18,682)
Net income (loss)	(14,564)																	(5,333)		(9,231)
Balance at the end at Jun. 30, 2022	$ 840,997										$ 22		$ 27		$ 495,642			$ (83,433)		$ 428,739
Balance at the end (in shares) at Jun. 30, 2022						218,028,952	264,527,434				218,028,952		264,527,434